An Overview of Cardiovascular Outcome Trials (CVOTs) in Type 2 Diabetes

An Overview of Cardiovascular Outcome Trials (CVOTs) in Type 2 Diabetes

Diabetes Core Update: SGLT-2 inhibitors – Cardiovascular Effects– Sept. 2020Подробнее

Diabetes Core Update: SGLT-2 inhibitors – Cardiovascular Effects– Sept. 2020

Dr Dharmendra Panchal - U Turn of CVOTs in Diabetes Treatment: Do we Really need Them?Подробнее

Dr Dharmendra Panchal - U Turn of CVOTs in Diabetes Treatment: Do we Really need Them?

Cardiovascular Disease Burden in Type 2 Diabetes: Strategies to Improve OutcomesПодробнее

Cardiovascular Disease Burden in Type 2 Diabetes: Strategies to Improve Outcomes

James R. Gavin III, MD, PhDПодробнее

James R. Gavin III, MD, PhD

Professor Stephen Wiviott - 'SGLT2 Outcome trials - an evolving story'Подробнее

Professor Stephen Wiviott - 'SGLT2 Outcome trials - an evolving story'

Darren McGuire | Cardiovascular effects of diabetes medications: Lessons learned from CVOTsПодробнее

Darren McGuire | Cardiovascular effects of diabetes medications: Lessons learned from CVOTs

Relevance of positive cardiovascular outcome trial results- Video Abstract ID 144362Подробнее

Relevance of positive cardiovascular outcome trial results- Video Abstract ID 144362

UCC presents Professor Neil R Poulter CV Outcome Trials in Type 2 Diabetes: A ReviewПодробнее

UCC presents Professor Neil R Poulter CV Outcome Trials in Type 2 Diabetes: A Review

Актуальное